Plasma-Based Genotyping for Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

This study assesses whether plasma-based next-generation sequencing was associated with improved mutation detection and enhanced delivery of personalized therapy in a real-world clinical setting of patients with non–small cell lung cancer.

https://ift.tt/2RFwAr0